Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sierra

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Vaccine|February 17, 2025
Human papillomavirus type 16 and 18 viral clearance and progression to precancer among women aged 18-25 years enrolled in the Costa Rica HPV prophylactic vaccine trial (CVT)Mónica S Sierra, Loretto J Carvajal, Peter Dull, et al.
International Journal of Cancer|January 18, 2023
Trends in incidence rates of head and neck squamous cell carcinomas overall and by potential relatedness to human papillomavirus, Costa Rica 2006 to 2015Loretto J Carvajal, Jaimie Z Shing, Juan C Vanegas, et al.
Nature Communications|February 21, 2024
Global evaluation of lineage-specific human papillomavirus capsid antigenicity using antibodies elicited by natural infectionGathoni Kamuyu, Filomeno Coelho da Silva, Vanessa Tenet, et al.
Experimental Neurology|June 27, 2014
CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatumE Martínez-Pinilla, I Reyes-Resina, A Oñatibia-Astibia, et al.
Lancet Regional Health. Americas|September 16, 2024
A surveillance study of cancer incidence and mortality among young adults in Costa RicaRachel Slimovitch, Jaimie Z Shing, Romain Fantin, et al.
Sexually Transmitted Infections|July 16, 2022
Analysis of cervical HPV infections among unvaccinated young adult women to inform vaccine strategies in this age group: the Costa Rica HPV Vaccine TrialMónica S Sierra, Sabrina H Tsang, Carolina Porras, et al.
Journal of the National Cancer Institute. Monographs|November 12, 2024
HPV16/18 antibodies 16-years after single dose of bivalent HPV vaccination: Costa Rica HPV vaccine trialCarolina Porras, Byron Romero, Troy Kemp, et al.
The Journal of Infectious Diseases|December 16, 2020
Risk Factors for Non-Human Papillomavirus (HPV) Type 16/18 Cervical Infections and Associated Lesions Among HPV DNA-Negative Women Vaccinated Against HPV-16/18 in the Costa Rica Vaccine TrialMónica S Sierra, Sabrina H Tsang, Shangying Hu, et al.
The Journal of Infectious Diseases|August 12, 2025
Validation of TypeSeq2, a Next-Generation-Based Sequencing Assay for the Detection of 46 Human Papillomavirus Genotypes, at the US National Cancer Institute and Costa Rica LaboratoriesMónica S Sierra, Carolina Coto, Carolina Porras, et al.
Vaccine|July 28, 2020
Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccinesSabrina H Tsang, Partha Basu, Noemi Bender, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Vaccine|February 17, 2025
Human papillomavirus type 16 and 18 viral clearance and progression to precancer among women aged 18-25 years enrolled in the Costa Rica HPV prophylactic vaccine trial (CVT)Mónica S Sierra, Loretto J Carvajal, Peter Dull, et al.
International Journal of Cancer|January 18, 2023
Trends in incidence rates of head and neck squamous cell carcinomas overall and by potential relatedness to human papillomavirus, Costa Rica 2006 to 2015Loretto J Carvajal, Jaimie Z Shing, Juan C Vanegas, et al.
Nature Communications|February 21, 2024
Global evaluation of lineage-specific human papillomavirus capsid antigenicity using antibodies elicited by natural infectionGathoni Kamuyu, Filomeno Coelho da Silva, Vanessa Tenet, et al.
Experimental Neurology|June 27, 2014
CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatumE Martínez-Pinilla, I Reyes-Resina, A Oñatibia-Astibia, et al.
Lancet Regional Health. Americas|September 16, 2024
A surveillance study of cancer incidence and mortality among young adults in Costa RicaRachel Slimovitch, Jaimie Z Shing, Romain Fantin, et al.
Sexually Transmitted Infections|July 16, 2022
Analysis of cervical HPV infections among unvaccinated young adult women to inform vaccine strategies in this age group: the Costa Rica HPV Vaccine TrialMónica S Sierra, Sabrina H Tsang, Carolina Porras, et al.
Journal of the National Cancer Institute. Monographs|November 12, 2024
HPV16/18 antibodies 16-years after single dose of bivalent HPV vaccination: Costa Rica HPV vaccine trialCarolina Porras, Byron Romero, Troy Kemp, et al.
The Journal of Infectious Diseases|December 16, 2020
Risk Factors for Non-Human Papillomavirus (HPV) Type 16/18 Cervical Infections and Associated Lesions Among HPV DNA-Negative Women Vaccinated Against HPV-16/18 in the Costa Rica Vaccine TrialMónica S Sierra, Sabrina H Tsang, Shangying Hu, et al.
The Journal of Infectious Diseases|August 12, 2025
Validation of TypeSeq2, a Next-Generation-Based Sequencing Assay for the Detection of 46 Human Papillomavirus Genotypes, at the US National Cancer Institute and Costa Rica LaboratoriesMónica S Sierra, Carolina Coto, Carolina Porras, et al.
Vaccine|July 28, 2020
Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccinesSabrina H Tsang, Partha Basu, Noemi Bender, et al.
Pageof 9